WPI 2265 (Acitretin 22.5 mg)
Pill with imprint WPI 2265 is Brown, Capsule-shape and has been identified as Acitretin 22.5 mg. It is supplied by Actavis Pharma, Inc..
Acitretin is used in the treatment of pityriasis rubra pilaris; psoriasis; psoriatic arthritis and belongs to the drug class antipsoriatics. Not for use in pregnancy. Acitretin 22.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WPI 2265
Acitretin
- Imprint:
- WPI 2265
- Strength:
- 22.5 mg
- Color:
- Brown
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Antipsoriatics
- Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Actavis Pharma, Inc.
- National Drug Code (NDC):
- 00591-2265
More about acitretin
- Acitretin Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 19 Reviews
- Drug class: antipsoriatics
Consumer resources
Other brands: Soriatane
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
